Alphamab Oncology (FRA:3NK)
1.190
-0.020 (-1.65%)
Last updated: Apr 24, 2026, 9:05 AM CET
59.73% (1Y)
| Market Cap | 1.21B +29.8% |
| Revenue (ttm) | 68.95M -11.5% |
| Net Income | -13.87M |
| EPS | -0.01 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Average Volume | 81 |
| Open | 1.190 |
| Previous Close | 1.210 |
| Day's Range | 1.190 - 1.190 |
| 52-Week Range | 0.645 - 1.680 |
| Beta | n/a |
| RSI | 62.40 |
| Earnings Date | Mar 25, 2026 |